title: Could treatment with R-HCVAD/R-MA as compared to R- CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell lymphoma? - Response to Landsburg et al.
authors: Department of Lymphoma and Myeloma, University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA.
authors: Jason
authors: J
authors: Westin
authors: Yasuhiro
authors: Y
authors: Oki
authors: Luis
authors: L
authors: Fayad
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008297:Male
keywords: chemotherapy; lymphoma; non-Hodgkin lymphoma